TXG is up 8.43% today. Volume is 3.10M vs a 30-day average of 3.79M (0.82x).
10x Genomics, Inc. is scheduled to report earnings Thu, Nov 5, 2026 · after close. Analysts expect EPS of $-0.26 on revenue of about $149.34M. Stocks often move sharply on earnings day.
10x Genomics, Inc. (Nasdaq: TXG), the life science technology leader focused on accelerating science and advancing human health, announced today that members of its management tea…
Ark's latest quarterly report shows that several stocks made meaningful contributions across multiple ETFs.
Analysts have lifted their Fair Value estimate for 10x Genomics from about US$62.13 to about US$75.67, a change of roughly 22% in the latest round of models. Much of this reset in…
What a fantastic six months it’s been for 10x Genomics. Shares of the company have skyrocketed 187%, hitting $72.70. This was partly thanks to its solid quarterly results, and the…